For more than half a century, major depressive disorder (MDD) has largely been interpreted through a neurochemical lens. The prevailing framework focused on deficiencies or imbalances in serotonin, norepinephrine, and dopamine, leading to generations of therapies designed to modulate synaptic signaling. While these approaches improved outcomes for many patients, they have not fundamentally solved the problem of durable remission. A significant proportion of patients remain treatment resistant, and relapse rates continue to challenge long-term disease management.
https://salienceclinical.com/
https://salienceclinical.com/
-
2 Yazı
-
1 Fotoğraflar
-
0 Videolar
-
Hayatımızda USA
-
Kimden USA
-
Male
-
Ardından: 0 people
Site içinde arama yapın
English
Arabic
French
Spanish
Portuguese
Deutsch
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek
